InvestorGain adds Buybacks & Authorizations, Secondary Offerings, New Issues & Calendars, Calendar, and Education coverage that PwC — IPO Watch EMEA (all editions) skips.
VOL. XCIV, NO. 247
★ FINANCIAL TOOLS & SERVICES DIRECTORY ★
PRICE: 5 CENTS
Monday, October 6, 2025
Head-to-head
InvestorGain vs PwC — IPO Watch EMEA (all editions) comparison
Compare pricing, supported platforms, categories, and standout capabilities to decide which tool fits your workflow.
Quick takeaways
PwC — IPO Watch EMEA (all editions) includes News, and Newsletters categories that InvestorGain omits.
InvestorGain highlights: Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP)., Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues., and IPO anchor investor allocation reports by year (mainboard & SME)..
PwC — IPO Watch EMEA (all editions) is known for: Quarterly EMEA IPO survey with totals by proceeds and deal count, plus charts (trend over time, by sector, by region)., Commentary on market drivers and outlook; highlights top deals and exchange rankings per period., and Breakouts for Europe vs EMEA vs UK, and regular references to Middle East/Africa activity..
InvestorGain ships a mobile app. PwC — IPO Watch EMEA (all editions) is web/desktop only.
InvestorGain
investorgain.com
India‑focused IPO & primary‑markets portal with live IPO subscription tracking, Grey Market Premium (GMP) dashboards, anchor investor allocations, and new‑issue calendars (NCDs, SGBs, rights). Provides broker reviews/comparisons and free brokerage calculators. GMP is expressly noted as based on market perception/public sources; the site states it does not work with GMP operators and content is for education/news. The business is ad/affiliate‑supported.
Categories
Platforms
Web
Mobile
Pricing
Free
Quick highlights
- Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP).
- Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues.
- IPO anchor investor allocation reports by year (mainboard & SME).
- IPO performance history and GMP‑vs‑actual listing performance trackers.
- Rights issues dashboard (record date, entitlement, pricing, timelines).
Community votes (overall)
0% upvotes 0% downvotes
You haven't voted yet
PwC — IPO Watch EMEA (all editions)
pwc.co.uk
Quarterly publication tracking the volume and value of IPOs across EMEA’s principal stock markets. Compiled by PwC’s London capital markets team, it covers new primary market listings and provides exchange/sector/country breakdowns, top deals and outlook. Methodology relies on S&P Capital IQ extracts with a $5m minimum raise threshold; excludes greenshoe, closed‑end funds/BDCs and OTC transactions; intra‑exchange market moves are excluded; dual listings attribute full proceeds to each exchange. Delivered as PDFs; no public API.
Categories
Platforms
Web
Pricing
Free
Quick highlights
- Quarterly EMEA IPO survey with totals by proceeds and deal count, plus charts (trend over time, by sector, by region).
- Commentary on market drivers and outlook; highlights top deals and exchange rankings per period.
- Breakouts for Europe vs EMEA vs UK, and regular references to Middle East/Africa activity.
- Clear methodology section in each PDF (data source, inclusion/exclusion rules, timestamp of data extract).
- Email sign‑up for future editions (‘IPO Watch quarterly insights’).
Community votes (overall)
0% upvotes 0% downvotes
You haven't voted yet
Overlap
Shared focus areas
2 overlapsMutual strengths include IPO, and Blogs.
Where they differ
InvestorGain
Distinct strengths include:
- Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP).
- Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues.
- IPO anchor investor allocation reports by year (mainboard & SME).
- IPO performance history and GMP‑vs‑actual listing performance trackers.
PwC — IPO Watch EMEA (all editions)
Distinct strengths include:
- Quarterly EMEA IPO survey with totals by proceeds and deal count, plus charts (trend over time, by sector, by region).
- Commentary on market drivers and outlook; highlights top deals and exchange rankings per period.
- Breakouts for Europe vs EMEA vs UK, and regular references to Middle East/Africa activity.
- Clear methodology section in each PDF (data source, inclusion/exclusion rules, timestamp of data extract).
Feature-by-feature breakdown
| Attribute | InvestorGain | PwC — IPO Watch EMEA (all editions) |
|---|---|---|
Categories Which research workflows each platform targets | Shared: IPO, Blogs Unique: Buybacks & Authorizations, Secondary Offerings, New Issues & Calendars, Calendar, Education | Shared: IPO, Blogs Unique: News, Newsletters |
Asset types Supported asset classes and universes | Stocks, Bonds | Stocks |
Experience levels Who each product is built for | Beginner, Intermediate, Advanced | Beginner, Intermediate, Advanced |
Platforms Where you can access the product | Web, Mobile | Web |
Pricing High-level pricing models | Free | Free |
Key features Core capabilities called out by each vendor | Unique
| Unique
|
Tested Verified by hands-on testing inside Find My Moat | Not yet | Not yet |
Editor pick Featured inside curated shortlists | Standard listing | Standard listing |
Frequently Asked Questions
Which workflows do InvestorGain and PwC — IPO Watch EMEA (all editions) both support?
Both platforms cover IPO, and Blogs workflows, so you can research those use cases in either tool before digging into the feature differences below.
Do InvestorGain and PwC — IPO Watch EMEA (all editions) require subscriptions?
Both InvestorGain and PwC — IPO Watch EMEA (all editions) keep freemium access with optional paid upgrades, so you can trial each platform before committing.
Which tool has mobile access?
InvestorGain ships a dedicated mobile experience, while PwC — IPO Watch EMEA (all editions) focuses on web or desktop access.
What unique strengths set the two platforms apart?
InvestorGain differentiates itself with Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP)., Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues., and IPO anchor investor allocation reports by year (mainboard & SME)., whereas PwC — IPO Watch EMEA (all editions) stands out for Quarterly EMEA IPO survey with totals by proceeds and deal count, plus charts (trend over time, by sector, by region)., Commentary on market drivers and outlook; highlights top deals and exchange rankings per period., and Breakouts for Europe vs EMEA vs UK, and regular references to Middle East/Africa activity..
Keep exploring
Stay on top of related tools
Browse the categories and profiles that overlap most with this comparison to round out your shortlist.
Related categories
Follow the same themes these tools compete in.
Recommended tools
These profiles share overlapping coverage with both sides of this matchup.
- IPO Watch (ipowatch.in)
Overlap: IPO, Buybacks & Authorizations, and Secondary Offerings.
IPOBuybacks & AuthorizationsSecondary Offerings - StockopediaEditor's pickHands-on review
Overlap: News, Calendar, and Education.
NewsCalendarEducation - Chittorgarh.com
Overlap: IPO, Secondary Offerings, and News.
IPOSecondary OfferingsNews - CapEdgeEditor's pickHands-on review
Overlap: News, Calendar, and IPO.
NewsCalendarIPO - Dividend.comHands-on review
Overlap: Calendar, News, and Blogs.
CalendarNewsBlogs - IPOScoopHands-on review
Overlap: IPO, Secondary Offerings, and Calendar.
IPOSecondary OfferingsCalendar
Curation & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.